EN中文
Home Page
About Us
Company Profile
Company Team
Scientific R&D
R&D
R&D Pipeline
Newsroom
News Center
Employee Corner
Contact Us
Join Us

Newsroom

Newsroom

News Center Employee Corner
25
2023.03
Good News! Chengdu SBK Successfully Passes On-Site Inspection for Class B “Drug Manufacturing Licen...
From March 24 to 25, 2023, a three-member expert team from the Evaluation Center of the Sichuan Medical Products Administration conducted a thorough on-site ins...
09
2023.02
A Promising Start! ∣ SBK Included in Growth Catalog and Selected as “Chengdu IPO Reserve Enterpris...
In a bid to support high-quality enterprises in securing IPO financing and drive Chengdu’s economic development, the Chengdu Local Financial Regulation Bureau,...
13
2023.01
A Strong Start to the New Year! “Four Key” Drug Development Drivers Propel Our Innovation Journey
Chengdu Shibeikang Biomedical Technology Co., Ltd. is kicking off the year with four major achievements in its proprietary drug development pipeline. With our d...
04
2023.01
Good News! SBK Selected for the “2022 Chengdu SME Growth Program Nurturing Enterprise”
We are excited to announce that SBK has been officially selected for the 2022 Chengdu SME Growth Program Nurturing Enterprises (Second Batch). SBK has been reco...
03
2023.01
Congratulations to Chengdu Shibeikang Biomedical Technology Co., Ltd. for Being Recognized as a ‘Si...
Recently, Chengdu Municipal Bureau of Economy and Information Technology released the Public Notice of Innovative SMEs List for Q4 2022. After a rigorous evalua...
上一页12345678...1011下一页
About Us
Company ProfileCompany Team
Scientific R&D
R&DR&D Pipeline
Newsroom
News CenterEmployee Corner
Contact Us
Join Us
(86)028 - 8798 8946
shibeikang@sbkswyy.cn
25-1-1, Tianfu Creative Industry Park, No.2 Tianyu Road, High-tech Zone, Chengdu
WeChat official account

© 2025版权所有 成都施贝康生物医药科技有限公司 蜀ICP备19024419号-1 -川公网安备 51012402000471号

Design&Technology:Cloud Technology